Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men

The American Journal of Cardiology
G L Vega, S M Grundy

Abstract

Our investigations indicate that most patients with moderate hypertriglyceridemia have marked defects in the metabolism of low-density lipoprotein (LDL) apolipoprotein B. Moreover, these patients have 2 major defects in the metabolism of triglyceride-rich lipoproteins, i.e., an accumulation of remnant lipoproteins (due in part to delayed hepatic clearance) and increased fractional conversion of very-low-density lipoprotein (VLDL) to LDL. Defective triglyceride-rich lipoprotein metabolism has been associated with insulin resistance. Statin therapy in hypertriglyceridemic patients improves the lipoprotein profile by decreasing both LDL cholesterol and remnant lipoproteins. However, statin therapy does not normalize LDL apolipoprotein B metabolism, and high-density lipoprotein (HDL) cholesterol levels remain low. Therefore, consideration may be given to combining a statin with a drug that alters triglyceride metabolism (e.g., fibrate or nicotinic acid) in high-risk patients with hypertriglyceridemia.

References

Jul 1, 1991·Circulation·G L VegaS M Grundy
Jun 1, 1988·Kidney International·G L Vega, S M Grundy
Jul 7, 1988·The New England Journal of Medicine·S M Grundy
Nov 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A H KissebahD J Evans
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M DammermanJ L Breslow

❮ Previous
Next ❯

Citations

Jun 8, 2001·The Journal of Clinical Investigation·G MartinB Staels
Aug 2, 2008·Archives of Toxicology·Oliver Adam, Ulrich Laufs
Jan 24, 2003·Clinical Cardiology·M John ChapmanFergus McTaggart
Sep 11, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·N LindbohmT A Miettinen
Jun 13, 2002·European Journal of Clinical Investigation·A-L García-OtínUNKNOWN ATOMIX Study Group. Atorvastatin in Mixed dyslipidemia
Jul 29, 2010·Current Medical Research and Opinion·Anthony S WierzbickiRichard Wray
Mar 5, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Simone R B M EussenJohan Garssen
Jul 22, 2005·Preventive Cardiology·Rahul GargRoger S Blumenthal
Nov 18, 1998·The American Journal of Cardiology·A M Gotto
Mar 18, 2004·Current Medical Research and Opinion·Kohji Shirai
Jun 20, 2003·Current Medical Research and Opinion·A S WierzbickiC B Byrne
Mar 10, 2001·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·T FunatsuK Miyata
Mar 18, 2003·Journal of Lipid Research·Samir S DeebJohn D Brunzell
Mar 17, 1999·Journal of Atherosclerosis and Thrombosis·J Fan, T Watanabe
Nov 22, 2000·Current Opinion in Lipidology·R J Havel
Aug 4, 1999·Current Opinion in Lipidology·J C CohenS M Grundy
Oct 26, 1999·The Annals of Pharmacotherapy·D R Guay
Oct 7, 2004·Journal of the American College of Nutrition·Andrea Rosanoff, Mildred S Seelig
Nov 1, 2005·QJM : Monthly Journal of the Association of Physicians·R OhashiC Chen
Mar 9, 2013·Expert Review of Cardiovascular Therapy·Shirya Rashid
Oct 31, 2019·Global Health & Medicine·Hidekatsu YanaiHiroshi Yoshida
May 1, 2021·Life·Carlo Maria BarbagalloEmilio Nardi
Apr 4, 1998·The American Journal of Cardiology·H N Ginsberg
Oct 12, 2004·Biochemical and Biophysical Research Communications·Takashi MaejimaY Saito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.